T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Price:
8.99
CNY
3.33%
Market Cap:
¥17.6B
Relative Value
The Relative Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 8.99 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tonghua Dongbao Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
17.6B CNY | 6.4 | 14.4 | 49.9 | 49.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD | 16.2 | 52.4 | 35.2 | 37.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP | 5.2 | 31.9 | 15.2 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
227.3B CHF | 5.2 | 20.3 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4 | 12.3 | 8.6 | 10 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD | 2.5 | 20 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
